Oncology Reports
Overview
Oncology Reports is a peer-reviewed journal dedicated to publishing high-quality research in the field of oncology. It covers a wide range of topics including cancer biology, diagnosis, treatment, and prevention. With a focus on clinical and translational research, this journal provides valuable insights into the latest advancements in cancer research and aims to improve patient outcomes.
Details
Details
Metrics
Metrics
h-index / Ranks: 2409
115
SJR / Ranks: 4717
864
CiteScore / Ranks: 2064
8.40
JIF / Ranks: 2095
4.2
Recent Articles
1.
Chen Y, Yang Z, Wu D, Min Z, Quan Y
Oncol Rep
. 2025 Mar;
53(5).
PMID: 40084703
Subsequently to the publication of the above paper, an interested reader drew to the authors' and the Editor's attention that the clone image featured in Fig. 4A for the 'NC'...
2.
Xu S, Wang H, Yan L, Han X
Oncol Rep
. 2025 Mar;
53(4).
PMID: 40084689
The current study aimed to investigate the effect of isoegomaketone (IK) as a radiosensitizer for colon cancer and its effect on intestinal injury, and to verify its potential mechanism. A...
3.
Ma Y, Jin Z, Huang J, Zhou S, Ye H, Jiang S, et al.
Oncol Rep
. 2025 Mar;
53(4).
PMID: 40052600
Following the publication of the above paper, a concerned reader drew to the Editor's attention that certain discrete western blot data shown in the RT‑qPCR blots in Figs. 1A and...
4.
Zhang L, Wang S, Wang L
Oncol Rep
. 2025 Mar;
53(4).
PMID: 40052583
As cancer incidence and mortality rates continue to rise, the urgency for research in this field has increased globally. Sideroflexin 1 (SFXN1), a pivotal member of the SFXN protein family,...
5.
Han H, Du A, Li J, Han H, Feng P, Zhu Y, et al.
Oncol Rep
. 2025 Feb;
53(4).
PMID: 40017136
Glioblastoma (GBM) is the most aggressive primary brain tumour, characterised by high heterogeneity, aggressiveness and resistance to conventional therapies, leading to poor prognosis for patients. In recent years, with the...
6.
Guo X, Li S
Oncol Rep
. 2025 Feb;
53(4).
PMID: 39981932
Prostate cancer (PCa) is second only to lung cancer in terms of death among men worldwide. Advanced PCa frequently results in bone metastases, which occur in ~90% of patients and...
7.
Tatsumi Y, Masuda T, Watanabe T, Utomo R, Zulfin U, Meiyanto E, et al.
Oncol Rep
. 2025 Feb;
53(4).
PMID: 39981920
Osteosarcoma (OS) is the most common malignant bone tumor in children and adolescents. Histone acetyltransferases (HATs), such as p300, CBP and PCAF, modulate numerous biological processes, including cellular proliferation and...
8.
Janakiram N, Mohammed A, Ravillah D, Choi C, Zhang Y, Desai D, et al.
Oncol Rep
. 2025 Feb;
53(4).
PMID: 39981915
Following the publication of the above article, an interested reader drew to the authors' attention that the RT‑PCR data panels shown in Fig. 3C, showing the effects of PBIT and...
9.
Chen J, He K, Li X, Wang M, Yang Z, Wang Z, et al.
Oncol Rep
. 2025 Feb;
53(4).
PMID: 39981914
Endometrial cysts of the ovary (EMC) may develop into endometriosis (EM)‑associated ovarian cancer over time (EAOC), but the pathogenesis of this disease has not been determined. In the present study,...
10.
Zhu Y, Huang F, Liu X, Hou Y, Huang Y
Oncol Rep
. 2025 Feb;
53(4).
PMID: 39950325
Despite advancements and refinements in the therapeutic approaches for hepatic malignancies, liver cancer remains a prevalent and deadly form of cancer, with its grim outlook posing as a significant clinical...